Eastbourne General Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01070667
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

dronedarone (multaq) (2 trials)

Drugs in Other Trials (1)

amiodarone (cordarone) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2